What are the causes of hyperkalemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Hyperkalemia

Primary Mechanisms

Hyperkalemia results from three fundamental mechanisms: decreased renal potassium excretion (most common), transcellular shift of potassium out of cells, or excessive potassium intake—with impaired renal excretion being the dominant cause in clinical practice. 1, 2

Decreased Renal Potassium Excretion

This is the most clinically significant mechanism and includes:

  • Chronic kidney disease: The incidence increases dramatically with severity of renal impairment, occurring in up to 73% of patients with advanced CKD 1
  • Acute kidney injury: Often accompanied by acute pancreatitis or hepatic failure, and was present in all cases of hyperkalemia-induced cardiac arrest in one retrospective analysis 3
  • Reduced sodium delivery to the distal nephron: Impairs the kidney's ability to excrete potassium 2
  • Decreased mineralocorticoid level or activity (hypoaldosteronism): Disrupts the hormonal regulation of potassium excretion 2, 4
  • Abnormalities in the cortical collecting duct: Direct tubular dysfunction prevents normal potassium secretion 2

Transcellular Potassium Shift

Potassium moves from intracellular to extracellular space due to:

  • Metabolic acidosis: Causes potassium to shift out of cells in exchange for hydrogen ions 1
  • Massive tissue breakdown: Rhabdomyolysis, tumor lysis syndrome, and severe burns release large amounts of intracellular potassium 3, 4
  • Hemolysis: Can occur in the body (true hyperkalemia) or in the test tube (pseudohyperkalemia) 1
  • Stored blood products: Release significant potassium during transfusion 3

Excessive Potassium Intake

Rarely causes hyperkalemia alone but contributes significantly when combined with impaired renal function:

  • Potassium supplements: Direct exogenous source 1
  • Salt substitutes: Often contain potassium chloride (e.g., DASH diet products) 1
  • High-potassium foods: Bananas, melons, orange juice, potatoes, tomatoes 1, 3
  • Herbal supplements: Alfalfa, dandelion, hawthorne berry, horsetail, nettle, noni juice, Siberian ginseng 1

Drug-Induced Hyperkalemia

Medications represent the most important iatrogenic cause of hyperkalemia in everyday clinical practice, with RAAS inhibitors being the most common culprits. 1, 5

Drugs That Decrease Potassium Excretion

  • RAAS inhibitors: ACE inhibitors, ARBs, direct renin inhibitors (aliskiren), and mineralocorticoid receptor antagonists cause hyperkalemia in up to 40% of heart failure patients and 5-10% when used in combination therapy 1, 3
  • Potassium-sparing diuretics: Spironolactone, triamterene, amiloride 1
  • NSAIDs: Impair renal potassium excretion by reducing prostaglandin synthesis 1, 3, 5
  • Calcineurin inhibitors: Cyclosporine, tacrolimus 1, 5
  • Antimicrobials: Trimethoprim-sulfamethoxazole, pentamidine 1, 5
  • Heparin and derivatives: Suppress aldosterone synthesis 1, 5
  • Other agents: Beta-blockers, sacubitril/valsartan, digitalis, penicillin G 1

Drugs That Promote Transcellular Shift

  • Beta-blockers: Impair cellular potassium uptake 1, 5
  • Suxamethonium: Causes rapid potassium release from muscle cells 5
  • Mannitol: Increases serum osmolality, drawing potassium out of cells 1, 5
  • Amino acids: Aminocaproic acid, arginine, lysine 1

High-Risk Comorbidities

Certain patient populations have dramatically elevated risk, with up to 73% of advanced CKD patients and 40% of chronic heart failure patients developing hyperkalemia. 1, 6

  • Chronic kidney disease: Risk increases proportionally with declining eGFR 1
  • Heart failure: Particularly heart failure with reduced ejection fraction (HFrEF) 1
  • Diabetes mellitus: Associated with hyporeninemic hypoaldosteronism 1, 7
  • Advanced age: Reduced renal function and polypharmacy increase risk 1
  • Arterial hypertension: Especially when treated with multiple RAAS inhibitors 1
  • Coronary artery disease: Often requires RAAS inhibitor therapy 1

Pseudohyperkalemia

Always rule out pseudohyperkalemia before initiating treatment, as this represents falsely elevated potassium in the test tube without true elevation in the body. 1, 3

  • Hemolysis during blood draw: Poor phlebotomy technique or delayed sample processing 1, 3
  • Prolonged tourniquet application: Causes local tissue ischemia and potassium release 1
  • Fist clenching during phlebotomy: Muscle activity releases potassium 1
  • Thrombocytosis or leukocytosis: Cells release potassium after collection 1

If pseudohyperkalemia is suspected, repeat measurement with proper blood sampling technique or obtain an arterial sample for confirmation. 1, 3

Critical Clinical Context

The prevalence varies dramatically by setting: 2-4% in the general population, 10-55% in hospitalized patients depending on severity thresholds used, and up to 73% in advanced CKD 1. Both the absolute potassium level and the rate of rise determine clinical significance—rapid increases are more likely to cause cardiac abnormalities than gradual elevations over months. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and treatment of hyperkalemia.

Cleveland Clinic journal of medicine, 2017

Guideline

Hyperkalemia Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pathogenesis, diagnosis and management of hyperkalemia.

Pediatric nephrology (Berlin, Germany), 2011

Research

Drug-induced hyperkalemia.

Drug safety, 2014

Guideline

Hyperkalemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hyperkalemia Management and Kidney Injury Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.